Intermittent pneumatic compression is a cost-effective method of orthopedic postsurgical venous thromboembolism prophylaxis

References

• JhaAKLarizgoitiaIAudera-LopezCPrasopa-PlaizierNWatersHBatesDWThe global burden of unsafe medical care: analytic modelling of observational studiesBMJ Qual Saf20132210809815
   PubMed Web of Science ®Google Scholar
• DeitelzweigSBJohnsonBHLinJSchulmanKLPrevalence of clinical venous thromboembolism in the USA: current trends and future projectionsAm J Hematol201186221722021264912
   PubMed Web of Science ®Google Scholar
• GrosseSDNelsonRENyarkoKARichardsonLCRaskobGEThe economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costsThromb Res201613731026654719
   PubMed Web of Science ®Google Scholar
• BarcoSWoerschingALSpyropoulosACPiovellaFMahanCEEuropean Union-28: an annualised cost-of-illness model for venous thromboembolismThromb Haemost2016115480080826607486
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and WelfareOECD health-care quality indicators for Australia 20152016 Available from https://www.aihw.gov.au/reports/international-comparisons/oecd-health-care-quality-indicators-2015/contents/table-of-contentsAccessed January 31, 2017
   Google Scholar
• Access EconomicsThe burden of venous thromboembolism in AustraliaReport for the Australia and New Zealand Working Party on the Management and Prevention of Venous Thromboembolism2008
   Google Scholar
• ChartersMAFrischNBWessellNMDobsonCLesCMSilvertonCDRivaroxaban versus enoxaparin for venous thromboembolism prophylaxis after hip and knee arthroplastyJ Arthroplasty20153071277128025724111
   PubMed Web of Science ®Google Scholar
• AssarehHChenJOuLHollisSJHillmanKFlabourisARate of venous thromboembolism among surgical patients in Australian hospitals: a multicentre retrospective cohort studyBMJ Open2014410e005502
   Web of Science ®Google Scholar
• MirkazemiCBereznickiLRPetersonGMThromboprophylaxis following hip and knee arthroplastyIntern Med J201343212412923402484
   PubMed Web of Science ®Google Scholar
• Australian Orthopaedic Association National Joint Replacement Registry2016 NJRR Annual Report Available from: https://aoanjrr.sahmri.com/de/annual-reports-2016Accessed January 31, 2017
   Google Scholar
• PeelTNChengACLiewDDirect hospital cost determinants following hip and knee arthroplastyArthritis Care Res (Hoboken)201567678279025470687
   PubMed Web of Science ®Google Scholar
• ColemanCILimoneBLBookhartBKModySHNutescuEACost-effectiveness analysis of extended duration anticoagulation with rivaroxaban to prevent recurrent venous thromboembolismThromb Res2014133574374924582461
   PubMed Web of Science ®Google Scholar
• HoggKKimptonMCarrierMCoyleDForgieMWellsPEstimating quality of life in acute venous thrombosisJAMA Intern Med2013173121067107223689427
   PubMed Web of Science ®Google Scholar
• EndenTWikHSKvamAKHaigYKløwNESandsetPMHealth-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT studyBMJ Open201338e002984
   Web of Science ®Google Scholar
• Falck-YtterYFrancisCWJohansonNAPrevention of VTE in orthopedic surgery patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelinesChest20121412 Supple278Se325S22315265
   PubMed Web of Science ®Google Scholar
• KhotAPolmearAVenous thromboembolismPractical General Practice6th edLondonElsevier2011639640
   Google Scholar
• KingDALPowREDickisonDMValePRApixaban versus enoxaparin in the prevention of venous thromboembolism following total knee arthroplasty: a single-centre, single-surgeon, retrospective analysisIntern Med J20164691030103727246450
   PubMed Web of Science ®Google Scholar
• FiessingerJ-NHuismanMVDavidsonBLXimelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trialJ Am Med Assoc20052936681689
   PubMed Web of Science ®Google Scholar
• LeeHYHwangJSJengJSWangJ DerQuality-adjusted life expectancy (QALE) and loss of QALE for patients with ischemic stroke and intracerebral hemorrhage: a 13-year follow-upStroke201041473974420150543
   PubMed Web of Science ®Google Scholar
• MercaldiCJSiuKSanderSDLong-term costs of ischemic stroke and major bleeding events among Medicare patients with nonvalvular atrial fibrillationCardiol Res Pract201211645469
   Google Scholar
• KakkosSKSzendroGGriffinMDaskalopoulouSSNicolaidesANThe efficacy of the new SCD response compression system in the prevention of venous stasisJ Vasc Surg200032593294011054225
   PubMed Web of Science ®Google Scholar
• HoKMTanJAStratified meta-analysis of intermittent pneumatic compression of the lower limbs to prevent venous thromboembolism in hospitalized patientsCirculation201312891003102023852609
   PubMed Web of Science ®Google Scholar
• ShahiAChenAFTanTLMaltenfortMGKucukdurmazFParviziJThe incidence and economic burden of in-hospital venous thromboembolism in the United StatesJ Arthroplasty20173241063106627866951
   PubMed Web of Science ®Google Scholar
• PowREValePRThromboprophylaxis in patients undergoing total hip and knee arthroplasty: a review of current practices in an Australian teaching hospitalIntern Med J201545329329925546267
   PubMed Web of Science ®Google Scholar
• SpyropoulosACLinJDirect medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizationsJ Manag Care Pharm200713647548617672809
   PubMed Web of Science ®Google Scholar
• JosephJELowJCourtenayBNeilMJMcGrathMMaDA single-centre prospective study of clinical and haemostatic risk factors for venous thromboembolism following lower limb arthroplastyBr J Haematol20051291879215801960
   PubMed Web of Science ®Google Scholar
• NelsonDWSimianuVVBastawrousALThromboembolic complications and prophylaxis patterns in colorectal surgeryJAMA Surg2015150871272026060977
   PubMed Web of Science ®Google Scholar
• DuffJWalkerKOmariAStrattonCPrevention of venous thromboembolism in hospitalized patients: analysis of reduced cost and improved clinical outcomesJ Vasc Nurs201331191423481876
   PubMedGoogle Scholar
• O’ConnellSBasharKBroderickBJThe use of intermittent pneumatic compression in orthopedic and neurosurgical postoperative patientsAnn Surg2016263588888926720432
   PubMed Web of Science ®Google Scholar
• LinkinsLO’donnellMJulianJAKearonCIntracranial and fatal bleeding according to indication for long-term oral anticoagulant therapyJ Thromb Haemost20108102201220720723030
   PubMed Web of Science ®Google Scholar
• SmytheMAKoerberJMMattsonJCThe incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospitalChest200713161644164917400685
   PubMed Web of Science ®Google Scholar
• PrandoniPLensingAWCogoAThe long-term clinical course of acute deep venous thrombosisAnn Intern Med19961251178644983
   PubMed Web of Science ®Google Scholar
• KahnSRGalanaudJ-PVedanthamSGinsbergJSGuidance for the prevention and treatment of the post-thrombotic syndromeJ Thromb Thrombolysis201641114415326780743
   PubMed Web of Science ®Google Scholar
• BriggsAHWeinsteinMCFenwickEALKarnonJSculpherMJPaltielADModel parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force-6Value Health201215683584222999133
   PubMed Web of Science ®Google Scholar
• CaroJJBriggsAHSiebertUKuntzKMModeling good research practices – overview: a report of the ISPOR-SMDM modeling good research practices task force-1Value Health201215679680322999128
   PubMed Web of Science ®Google Scholar
• SiebertUAlagozOBayoumiAMState-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force-3 background to the task forceValue Health201215681282022999130
   PubMed Web of Science ®Google Scholar
• ZhangJChenZZhengJBreuschSJTianJRisk factors for venous thromboembolism after total hip and total knee arthroplasty: a meta-analysisArch Orthop Trauma Surg2015135675977225854654
   PubMed Web of Science ®Google Scholar
• NicholsCIVoseJGClinical outcomes and costs within 90 days of primary or revision total joint arthroplastyJ Arthroplasty201631714001406.e326880328
   PubMed Web of Science ®Google Scholar
• FernandezMMHogueSPreblickRKwongWJReview of the cost of venous thromboembolismClinicoecon Outcomes Res2015745146226355805
   PubMed Web of Science ®Google Scholar
• SchweizerMLCullenJJPerencevichENVaughan SarrazinMSCosts associated with surgical site infections in Veterans Affairs HospitalsJAMA Surg201452246617
   Google Scholar
• BullanoMFWilleyVHauchOWygantGSpyropoulosACHoffmanLLongitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalizationJ Manag Care Pharm200511866367316194130
   PubMedGoogle Scholar
• BackesMSchepNWLLuitseJSKCarel GoslingsJSchepersTThe effect of postoperative wound infections on functional outcome following intra-articular calcaneal fracturesArch Orthop Trauma Surg201513581045105225913906
   PubMed Web of Science ®Google Scholar
• CreekmoreFMOderdaGMPendletonRCBrixnerDIIncidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolismPharmacotherapy200626101438144516999654
   PubMed Web of Science ®Google Scholar
• CapriniJABottemanMFStephensJMEconomic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United StatesValue Health200361597412535239
   PubMed Web of Science ®Google Scholar
• NeumannPJCohenJTWeinsteinMCUpdating cost-effectiveness – the curious resilience of the $50,000-per-QALY thresholdN Engl J Med2014371979679725162885
   PubMed Web of Science ®Google Scholar
• ParisVBelloniAValue in pharmaceutical pricingOECD Health Working Papers, No. 632013174
   Google Scholar
• AmberRACP recommendations for VTE prophylaxis in hospitalized patientsAm Fam Physician201285121204
   Web of Science ®Google Scholar
• RivaNBellesiniMDi MinnoMNDPoor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolismThromb Haemost2014112351152124899092
   PubMed Web of Science ®Google Scholar
• ChibbaroSCebulaHTodeschiJEvolution of Prophylaxis Protocols for Venous Thromboembolism in Neurosurgery: Results from a Prospective Comparative Study on Low-Molecular-Weight Heparin, Elastic Stockings, and Intermittent Pneumatic Compression DevicesWorld Neurosurg2017109e510e51629033376
   PubMed Web of Science ®Google Scholar
• Mostafavi TabatabaeeRRasouliMRMaltenfortMGParviziJCost-effective prophylaxis against venous thromboembolism after total joint arthroplasty: warfarin versus aspirinJ Arthroplasty201530215916425534862
   PubMed Web of Science ®Google Scholar
• ZindelSStockSMüllerDEconomic evaluation of dabigatran etexilate for the primary prevention of venous tromboembolic events following major orthopedic surgery in the NetherlandsPharmacoeconomics2015132376383
   Google Scholar
• KapoorAChuangWRadhakrishnanNCost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic reviewPharmacoeconomics201028752153820550220
   PubMed Web of Science ®Google Scholar
• National Efficient Price Determination 2016–17Independent Hospital Pricing Authority2016 Available from https://www.ihpa.gov.au/sites/g/files/net636/f/publications/final_nep16_determination.pdfAccessed January 31, 2017
   Google Scholar
• ScherzNMeanMLimacherAProspective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolismJ Thromb Haemost201311343544323279158
   PubMed Web of Science ®Google Scholar